ENTITY
Shanghai Medicilon

Shanghai Medicilon (688202 CH)

55
Analysis
Health CareChina
Shanghai Medicilon Inc. develops pharmaceutical products. The Company produces acquired immune deficiency syndrome drugs, anticancer drug sensitizers, genetic engineering vaccines, biomedical intermediates, and other products. Shanghai Medicilon also provides biological analysis, drug safety evaluation, and other services.
more
07 May 2024 06:57

STAR100 Index Rebalance Preview: Potential Adds Continue to Push Higher

There could be 9 changes for the STAR100 Index in June of which 3 are migrations with the STAR50. The outright adds have outperformed the outright...

Logo
411 Views
Share
29 Apr 2024 11:34

STAR100 Index Rebalance Preview: 10 Changes as Potential Adds Outperform

Excluding the migrations to/from the STAR50 Index, there has been strong outperformance over the recent past and that could continue for the next...

Logo
657 Views
Share
25 Feb 2024 10:00

STAR50 Index Rebalance: Three Changes a Side; One Surprise Change

There are 3 changes for the STAR50 in March. Estimated one-way turnover is 2.9% resulting in a 1-way trade of CNY 4.08bn with over 2.5x ADV to...

Logo
571 Views
Share
01 Feb 2024 07:18

STAR50 Index Rebalance Preview: Sustaining Outperformance on Expected Impact

There could be 3 changes for the STAR50 Index in March. One-way turnover is estimated at 2.4% leading to a one-way trade of CNY 2.9bn. The...

Logo
566 Views
Share
21 Dec 2023 06:20

STAR50 Index Rebalance Preview: Four High Impact Changes in March

There could be 4 changes for the STAR50 Index in March. Passive trackers will need to trade between 1.2-9.7x ADV on the adds/dels. There will be...

Logo
768 Views
Share
x